We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Abbott to Acquire St. Jude Medical

By HospiMedica International staff writers
Posted on 09 May 2016
Print article
Abbott (Abbott Park, IL, USA) will pay USD 25 billion for St. Jude Medical (SJM, St. Paul, MN, USA), with the declared intention of creating a premier medical device company.

St. Jude Medical's strong positions in heart failure (HF), atrial fibrillation (AF) and cardiac rhythm management devices will complement Abbott's leading positions in coronary intervention and transcatheter mitral valve replacement (TMVR). Together, the combined company will also have a development pipeline expected to deliver a steady stream of new medical devices across cardiovascular, diabetes, vision, and neuromodulation patient care.

Examples of such products include the SJM EnSite Precision next-generation cardiac mapping system; multiPoint pacing technology to advance quadripolar technology and cardiac resynchronization therapy; and the Proclaim Elite recharge-free spinal cord stimulation system, among others. Abbott contributes the FreeStyle Libre sensor-based glucose monitoring system; the Tecnis Symfony, a continuous range of vision intraocular lens for the treatment of cataracts; and the Absorb bioresorbable coronary stent.

“Bringing together these two great companies will create a premier medical device business and immediately advance Abbott's strategic and competitive position,” said Miles D. White, chairman and CEO of Abbott. “The combined business will have a powerful pipeline ready to deliver next-generation medical technologies and offer improved efficiencies for health care systems around the world.”

“Our combined scale will expand the global reach, competitiveness and impact of our medical device innovation for physicians and hospitals,” said Michael Rousseau, president and CEO of St. Jude Medical. “This transaction provides our shareholders with immediate value and the opportunity to participate in the significant upside potential of the combined organization. I'd like to thank our 18,000 employees whose hard work and commitment help us deliver leading medical technologies to patients around the world.”

Under the agreement, St. Jude Medical shareholders will receive a cash payment and shares of Abbott common stock, representing a total consideration of approximately USD 85 per share; the cash portion of the agreement will be funded with medium- and long-term debt. Abbott will also take on St. Jude Medical's USD 5.7 billion in debt.

Related Links:
Abbott
St. Jude Medical
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Multipurpose Gynecological Table
Dixion Grace 8400

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.